/PRNewswire/ AllianceRx Walgreens Pharmacy has received exclusive access to Phospholine Iodide® (echothiophate iodide for ophthalmic solution) from Fera.
James Fitzella, a senior professional staffer for House Rules ranking member Tom Cole (R-Okla.), is heading back to K Street to join the Vogel Group as a director.
Press ReleaseNicox's Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcinod for the Treatment of Sickle Cell DiseaseMarch 2nd, 2022 - release at 7:30 am CET Sophia
Global Anti-Glaucoma Drug Market Top Manufacturers, Latest Innovation with Trends and Forecast 2021 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Nicox Provides Fourth Quarter 2020 Business Update and Financial Highlights
Nicox Provides Fourth Quarter 2020 Business Update and Financial Highlights
Initiated two large clinical trials: Denali, the second Phase 3 of NCX 470 in glaucoma, and Mississippi, a Phase 2b of NCX 4251 in blepharitis
Phase 3 clinical trial of ZERVIATE in allergic conjunctivitis initiated by partner Ocumension Therapeutics in China
U.S. prescriptions for VYZULTA
TM by 56% over Q3 2020
Q4 2020 net revenue of €5.8 million, full year 2020 net revenue of €8.9 million and cash of €47.8 million at December 31, 2020 January 20, 2021 - release at 7:30 am CET
Sophia Antipolis, France
Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today provided a business update and financial highlights for Q4 2020 for Nicox SA and its subsidiaries (the Nicox Group ), as well as key expected value-inflection milestones in 2021.